Study for people with keratoconus at a specialty eye clinic
Part of Eyes & vision clinical trials.
This trial is for people who have keratoconus (a cornea condition that can blur vision). It involves receiving care or evaluation at the Homburg Keratoconus Center, and it may help by improving how keratoconus patients are managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with keratoconus
- You should be receiving care at the Saarland University Medical Center (Homburg, Germany)
- You must be an ophthalmology (eye) patient at that department
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with or at risk for keratoonus, a condition where the cornea thins and bulges. It aims to improve early detection and understand how the disease progresses.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
This trial uses special eye imaging to measure how your cornea (the eye’s clear front surface) changes, and then builds a personalized model for you. It may help doctors plan safer, more tailored treatment for keratoconus—especially if you’re considering LASIK.
This study looks at the results of a surgical procedure called CTAK (Corneal Tissue Addition Keratoplasty) for people with keratoconus or similar corneal thinning conditions. The goal is to see how safe and effective this surgery is for improving vision.
This study tests whether a special eye scan called OCT can better identify causes of irregular cornea shape. Results may help doctors sort out different cornea problems so treatment choices, like certain procedures, can be more targeted.
This study looks at how people with keratoconus decide to take part in clinical research. It's for people who haven't had any treatment for keratoconus yet, and it may help improve future research studies for this condition.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.